-
Top Performing Health Care Stocks in January
Wednesday, February 1, 2012 - 7:32am | 981Here's a quick look at some of the top performing health care stocks, year to date. These stocks all have a market cap of more than $1 billion and all pay a dividend. Baxter International (NYSE: BAX) is more than 11% higher than a month ago, and more than 17% higher than a year ago. The company...
-
Jefferies Maintains Hold on PerkinElmer (PKI)
Friday, March 25, 2011 - 8:35am | 94Jefferies is out with its report today on PerkinElmer (NYSE: PKI), maintaining Hold, and its $26 PT. In a note to clients, Jefferies writes, "PKI will acquire CambridgeSoft and ArtusLabs, designers of laboratory software and systems management solutions, for $220M, or ~3.4 times anticipated...
-
Cramer's St. Patrick's Day Picks (PKI, WFC)
Thursday, March 17, 2011 - 2:48pm | 241This afternoon on CNBC, Jim Cramer said that with regard to Perkinelmer Inc. (NYSE: PKI), “it's nice to see a company doing extraordinarily well.” “They do a lot of Chinese water testing, so they're already there,” Cramer said. “They do it all. Whatever' wrong ing the water, they spot it. I bet...
-
President Obama's FY2012 Budget Details Released
Monday, February 14, 2011 - 10:21am | 244Deutsche Bank has published a research report on Healthcare Services & Technology after President Obama released details on his FY2012 budget this morning. In the report, Deutsche Bank writes "The budget is primarily focused on deficit reduction, but the budget for the NIH was actually provided...
-
Jefferies Initiates Coverage On SIRO, XRAY, CALP, DENX, DHR, PKI
Wednesday, October 6, 2010 - 9:23am | 91Jefferies & Co. has initiated coverage for the following companies: Sirona Dental Systems (NASDAQ: SIRO) Hold Dentsply (NASDAQ: XRAY) Buy, $40 price target Caliper Life Sciences (NASDAQ: CALP) Buy, $6 price target Dionex (NASDAQ: DNEX) Hold Danaher (NYSE: DHR) Buy, $52 price target PerkinElmer...
-
Life Sciences Research From Jefferies
Monday, September 27, 2010 - 8:52am | 197Jefferies & Co. has published a research report for Life Sciences, reporting: "Median short interest for listed and OTC Life Science Research Supply stocks rose 1% from the second half of August, while aggregate short interest levels were essentially unchanged (vs. a 1% increase for Nasdaq and...